The Food and Drug Administration (FDA) has released the following information.

PRODUCT
a) Premarin Tablets (conjugated estrogens tablets, USP), 0.625 mg,
100 tablet unit dose packages;
100 tablet bottles; and 5,000 tablet bottles. Rx only.
Recall # D-263-3;
b) Premphase Tablets, 0.625 mg/5 mg (conjugated estrogens 0.625 mg
and medroxyprogesterone acetate 5 mg tablets), Ez-dial dispenser
containing 28 tablets, Rx only. Recall # D-264-3.

CODE
a) Lot #s: A09049 exp. April 2004 (100-tablet bottles);
A09041 exp. April 2004 (5,000-tablet bottles);
A09067 exp. April 2004 (100-tablet unit dose packages);
b) Lot #s: A09065 Exp. 11/03; A12270 Exp. 12/03; A09069, Exp. 12/03.

RECALLING FIRM/MANUFACTURER
Robins Division of Wyeth, Richmond, VA, by letters on/about May 16, 2003. Firm initiated recall is ongoing.

REASON
Dissolution failure; 18 month stability station-2 hour time point.

VOLUME OF PRODUCT IN COMMERCE
111,605 units.

DISTRIBUTION
Nationwide.